Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 31

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 31
---
 able to successfully implement our business expansion plan, such as extension of our sales into new markets beyond Hong Kong. If we fail to implement our business growth plan, our business prospectus, results of operations and financial condition may be materially and adversely affected.

Unfavorable publicity or consumer acceptance of our products generally could reduce our sales.

Our business sustainability and growth rely upon
consumer awareness and acceptance of our homeopathic products. Consumer acceptance of products can be significantly influenced by scientific
research or findings, national media attention and other publicity about product use and our company generally. A product may initially
be received favorably, resulting in high sales that may not be sustainable as consumer preferences change. Alternatively, skepticism
of claims made by entities in the healthcare and wellness industry may limit the number of individuals that believe our consumer products
are effective, which may negatively affect our ability to generate significant sales from our products.

We are committed to consumer education via various approaches, such as industry forum presentations, regular trainings, and mentor and mentee network. However, changing, nurturing and enhancing consumer acceptance or behavior patterns may take months or years to accomplish and there is no guarantee that we will be successful in doing so. There is no guarantee that consumers will be willing to use our products. If consumers are not willing to purchase our products, our ability to generate significant revenue from the sale of our consumer product may be limited and our business, financial condition and results of operations may be adversely affected.

<div align='center'>17</div>

In addition, publicity or publications in the
form of published scientific research, statements by regulatory authorities, competitors, customers or otherwise, whether or not accurate,
could be unfavorable to homeopathy or any of our particular products. Adverse publicity in any form, whether or not accurate, that associates
use of our products or any other similar products with adverse events, that questions the benefits of our or similar products, that claims
that such products are ineffective or that alleges our labeling or promotional statements and materials do not comply with applicable
laws, regulations or policies could have a material adverse effect on our reputation, business, financial condition or results of operations.
We have been subject to negative publicity from time to time, including negative publicity on our product, LIVING Colloidal Silver, and
cannot rule out the possibility of future negative publicity on this and all of our other products, whether or not accurate. For example,
the Hong Kong Department of Health issued a press release on February 27, 2023 on a case of silver